New Directions Technology Consulting, LLC:

Who:

  

Napoleon Monroe, managing director, New Directions Technology Consulting (New Directions), the inventor of five U.S. patents with granted medication telemanagement claims. New Directions is the exclusive market developer of these patents, included in the mMed patent portfolio.

 

What:

Monroe will present “Benefits of IP Partnering for Drug Delivery Telemanagement Technologies” at the Drug Delivery Partnerships 2016 conference:

 
The presentation will:
-- Define potential partners
-- Identify for which stakeholders IP is most important or valuable
-- Specify benefits of IP partnering in smart medication telemanagement
-- Discuss how partnering with New Directions on IP can work to the benefit of multiple partners
 
[Monroe also will be participating in the (closed-door) Executive Leadership Boardroom.]
 

When/

Venue:

 Wednesday, Jan. 20, 2016; 12:15 pm
Canterbury Room
PGA National Resort & Spa
400 Avenue of the Champions
Palm Beach Gardens, FL 33418
 

Why:

 The point of care for drug treatment is wherever the patient doses. Improving medication adherence/compliance can improve outcomes, as well as help to reduce the cost of healthcare. Medication telemanagement also can provide great business opportunities for healthcare stakeholder partnerships, particularly at a time when stakeholders are being asked to demonstrate evidence-based outcomes and improve quality of life. With mobility being crucial to quality of life, there is a strong rationale for a Pharma emphasis on medication telemanagement. Service beyond the script is now an important part of strategies to gain and retain patients/customers.
 

Note: mMed is a trademark of New Directions Technology Consulting, LLC.